An expanding next-generation sequencing (NGS) oncology portfolio is helping VR真人彩票 drive the revolution in cancer genomics. Our NGS and microarray technologies are among the most trusted in the world. Our sample-to-data solutions deliver high-quality, reproducible results to speed the discovery and analysis of cancer-related variants鈥攁nd potentially transform the cancer care cycle.
We鈥檙e committed to advancing and individualizing the way cancer will be identified and treated. We want to partner with you in helping propel progress in personalized oncology. Together we can work toward achieving our ultimate goal: to make discoveries that will make a life-changing difference to cancer patients and their loved ones.
Keep ahead of the genomics technology curve to improve the quality of your research.
Expand your sequencing capabilities鈥攁nd the accuracy and potential impact of your lab.
Enhance the power and promise of your companion diagnostics capabilities.
In this talk, Swetha Anandhan from the MD Anderson Cancer Center will highlight the use of single cell RNA-sequencing to identify a unique population of macrophages in glioblastoma multiforme that persists after treatment with immune checkpoint inhibitors.
View Webinar